- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06646796
Yoga Impact in Fibromyalgia, Primary Health Care
October 15, 2024 updated by: Ines Rosendo, University of Coimbra
Fibromyalgia: Impact on Pain, Quality of Life of a Complementary Therapy on Primary Health Care
This study aims to evaluate the effectiveness of a complementary therapy using Yoga within the scope of First Health Care in Portugal, in pain control, quality of life and well-being of the patients with Fibromyalgia.
It also, pretends to assess the viability and to identify the barriers to this sort of therapy in the context of Primary Health Care.
Study Overview
Detailed Description
Fibromyalgia is a chronic and debilitating pain syndrome characterized by widespread and persistent pain, also affecting sleep quality and cognitive function.
It is estimated to affect 3.6% of the population; however, since it is a condition that is often underdiagnosed, the actual numbers may be higher.
It is also an incurable disease, so treatment is based on symptom management through pharmacological therapy, which is not always effective.
Due to the inadequacy of pharmacological therapy, there is a need for complementary therapies, and despite the limited number of studies conducted in this area, some therapies based on meditative movement (notably yoga) are beginning to emerge, with beneficial effects reported on pain management and quality of life in these patients.
Therefore, this study aims to investigate the benefits and feasibility of this type of intervention at the Primary Health Care level.
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Inês Rosendo Silva, MD PhD
- Phone Number: (351) 918-4186
- Email: inesrcs@gmail.com
Study Locations
-
-
-
Coimbra, Portugal, 3000-174
- USF Coimbra Centro
-
Contact:
- Inês R Silva, MD PhD
- Phone Number: +351918418663
- Email: inesrcs@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Users of the Family Health Unit diagnosed with Fibromyalgia;
- With cognitive capacity to answer the questionnaire;
- With physical capacity to take part in Yoga classes.
Exclusion Criteria:
- people under 18 years old.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
Group used as comparison.
|
|
|
Experimental: Intervention group
Yoga practioner group with a certified teacher, 3 times a week during 3 months.
|
Yoga with certified teacher, 3 times a week during 3 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life
Time Frame: at the beggining and up to 3 months
|
EQ-5D
|
at the beggining and up to 3 months
|
|
Pain
Time Frame: at the beggining and up to 3 months
|
Visual scale from 0 to 10 to measure pain
|
at the beggining and up to 3 months
|
|
Global perception of change
Time Frame: up to 3 months
|
Patient Global Impression of Change scale (portuguese validated version) 1 to 7 (1 is the worst, 7 is the best) |
up to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Well-being
Time Frame: at the beggining and up to 3 months
|
EADS-21
|
at the beggining and up to 3 months
|
|
Benefits perceived
Time Frame: up to 3 months
|
Open question answered by the patients trough a written text
|
up to 3 months
|
|
Difficulties perceived
Time Frame: up to 3 months
|
Open question answered by the patients trough a written text
|
up to 3 months
|
|
Replicability and ease of introducing treatment in the context of the Portuguese national health service
Time Frame: up to 3 months
|
Open questions and SWOT analysis
|
up to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Cabo-Meseguer A, Cerda-Olmedo G, Trillo-Mata JL. Fibromyalgia: Prevalence, epidemiologic profiles and economic costs. Med Clin (Barc). 2017 Nov 22;149(10):441-448. doi: 10.1016/j.medcli.2017.06.008. Epub 2017 Jul 19. English, Spanish.
- Prabhakar A, Kaiser JM, Novitch MB, Cornett EM, Urman RD, Kaye AD. The Role of Complementary and Alternative Medicine Treatments in Fibromyalgia: a Comprehensive Review. Curr Rheumatol Rep. 2019 Mar 4;21(5):14. doi: 10.1007/s11926-019-0814-0.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 1, 2024
Primary Completion (Estimated)
February 28, 2025
Study Completion (Estimated)
April 30, 2025
Study Registration Dates
First Submitted
September 17, 2024
First Submitted That Met QC Criteria
October 15, 2024
First Posted (Actual)
October 17, 2024
Study Record Updates
Last Update Posted (Actual)
October 17, 2024
Last Update Submitted That Met QC Criteria
October 15, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 067/2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
Italian Association for the Research and the Scientific...Not yet recruiting
-
Ionclinics & Deionic SLHospital Clínico Universitario de ValenciaNot yet recruitingFibromyalgia (FM)Spain
-
Ain Shams UniversityRecruiting
-
Selcuk UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...CompletedFibromyalgia (FM)Spain
-
Istanbul Gelisim UniversityBahçeşehir UniversityCompleted
-
Gazi UniversityCompletedFibromyalgia SyndromeTurkey (Türkiye)
-
University of UtahRecruitingFibromyalgia (FM)United States
-
María Catalina Osuna PérezActive, not recruitingFibromyalgia SyndromeSpain
Clinical Trials on Yoga
-
Universität Duisburg-EssenCompleted
-
Ataturk UniversityKTO Karatay UniversityRecruiting
-
Adiyaman University Research HospitalCompletedDepression | Stress | Anxiety | Psychological ResilienceTurkey
-
NMP Medical Research InstituteYog-Kulam; Department of Zoology, University of Rajasthan, IndiaCompleted
-
NMP Medical Research InstituteWarwick Research Services; Yog-KulamCompleted
-
Northwestern UniversityCompleted
-
University of MinnesotaCompleted
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedDepression | Pain | Breast Cancer | FatigueUnited States
-
Saglik Bilimleri UniversitesiThe Scientific and Technological Research Council of TurkeyCompletedStress | Anxiety | Telerehabilitation | Yoga | University StudentsTurkey
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedProstate CarcinomaUnited States